| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/06/2008 | US7368260 Antidiabetic agents; lipophilic |
| 05/06/2008 | US7368254 Lipid-based systems for targeting diagnostic agents |
| 05/06/2008 | US7368144 Removal of shell, pulp; grinding in presence of solvent; macerating, extraction. filtration |
| 05/06/2008 | US7368126 Controlled release depot formulations |
| 05/06/2008 | US7368110 Antibodies, including Fv molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their use |
| 05/06/2008 | US7368104 Glycopyrrolate in sustained releae form; antimuscarinic agents |
| 05/06/2008 | US7368102 Pulmonary delivery of aminoglycosides |
| 05/06/2008 | US7368098 Use of biomolecular targets in the treatment and visualization of tumors |
| 05/06/2008 | US7367934 Methods of enhancing radiation effects with metal nanoparticles |
| 05/06/2008 | CA2609766A1 Product for the management of inflammations, pressure sores and/or oral sores (aphthas) as well as the use of such product |
| 05/06/2008 | CA2468679C Antibiotic formulation and a method of making this formulation |
| 05/06/2008 | CA2463619C Stabilized azithromycin compositions |
| 05/06/2008 | CA2440331C Atorvastatin calcium in a pharmaceutical form, composition thereof, and pharmaceutical formulation comprising atorvastatin calcium |
| 05/06/2008 | CA2400133C Anaesthetic composition |
| 05/06/2008 | CA2378987C A binder for pharmaceutical compositions |
| 05/06/2008 | CA2376780C Intraocular tension lowering compositions for topical administration |
| 05/06/2008 | CA2345675C Two chamber cartridge for atomizers |
| 05/06/2008 | CA2311311C Biodegradable intra vaginal devices |
| 05/06/2008 | CA2283868C Photosensitizer conjugates for pathogen targeting |
| 05/06/2008 | CA2279795C Methods of making an emulsified composition |
| 05/02/2008 | WO2008052187A2 Antibodies and immunoconjugates and uses therefor |
| 05/02/2008 | WO2008052033A2 Ibuprofen composition |
| 05/02/2008 | WO2008051889A1 Rapid release mini-tablets provide analgesia in laboratory animals |
| 05/02/2008 | WO2008051864A2 Method of treating spinal internal disk derangement |
| 05/02/2008 | WO2008051565A2 A drug-release composition having a therapeutic carrier |
| 05/02/2008 | WO2008051383A2 Use of alcohol co-solvents to improve pegylation reaction yields |
| 05/02/2008 | WO2008051363A2 Stable polypeptide formulations |
| 05/02/2008 | WO2008051291A2 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof |
| 05/02/2008 | WO2008050896A1 Aqueous pharmaceutical suspensions containing rebamipide and manufacturing process thereof |
| 05/02/2008 | WO2008050871A1 Crystalline carbapenem compounds |
| 05/02/2008 | WO2008050866A1 Preparation containing highly purified botulinum toxin type a derived from infant botulism pathogen |
| 05/02/2008 | WO2008050848A1 Adhesive preparation |
| 05/02/2008 | WO2008050847A1 Granular preparation prevented from caking |
| 05/02/2008 | WO2008050776A1 Ophthalmic aqeous liquid preparation |
| 05/02/2008 | WO2008050673A1 Adhesive skin patch |
| 05/02/2008 | WO2008050491A1 Film preparation for forming film on skin |
| 05/02/2008 | WO2008050341A2 Novel psychotropic agents having glutamate nmda activity |
| 05/02/2008 | WO2008050188A2 Sustained release pharmaceutical compositions of alfuzosin and process for preparation thereof |
| 05/02/2008 | WO2008050157A2 Ozonated oil formulations |
| 05/02/2008 | WO2008049931A1 Peptide extended insulins |
| 05/02/2008 | WO2008049711A1 Peptide extended insulins |
| 05/02/2008 | WO2008049631A1 Sustained release formulations comprising very low molecular weight polymers |
| 05/02/2008 | WO2008049620A1 Semi-solid controlled release composition |
| 05/02/2008 | WO2008049385A1 Process for obtaining leguminous protein fractions of moderate molecular weight, leguminous protein fractions and use thereof |
| 05/02/2008 | WO2008049367A1 The use of plant seed protein extract and the pharmaceutical composition thereof |
| 05/02/2008 | WO2008049227A1 Multimeric tie 2 agonists and uses thereof in stimulating angiogenesis |
| 05/02/2008 | WO2008049178A1 Stable and ready-to-use oil-in-water propofol microemulsion |
| 05/02/2008 | WO2008030557A3 Compositions and methods for enhancing transport through mucus |
| 05/02/2008 | WO2008026765A3 Lyophilized preparation |
| 05/02/2008 | WO2007128923A3 Method for the preparation of a biocompatible gel with controlled release of one or more active ingredients with low solubility in water, gels thus obtained and their use |
| 05/02/2008 | WO2007108013B1 Novel bioconjugates as therapeutic agent and synthesis thereof |
| 05/02/2008 | WO2007064762A3 Conjugates of amino acids and vitamin b3 for percutaneous delivery of vitamin b3 |
| 05/02/2008 | WO2007061796A3 Pharmaceutical composition comprising high-potency sweetener |
| 05/02/2008 | WO2007042281B1 Processing of chitosan and chitosan derivatives |
| 05/02/2008 | CA2693383A1 Multimeric tie 2 agonists and uses thereof in stimulating angiogenesis |
| 05/02/2008 | CA2667791A1 Methods of therapeutic treatment of eyes and other human tissues using an oxygen-enriched solution |
| 05/02/2008 | CA2667536A1 Highly purified type a botulinum toxin preparation from infant botulism pathogen |
| 05/02/2008 | CA2667424A1 Sustained release formulations comprising very low molecular weight polymers |
| 05/02/2008 | CA2667325A1 A drug-release composition having a therapeutic carrier |
| 05/02/2008 | CA2667019A1 Antibodies and immunoconjugates and uses therefor |
| 05/02/2008 | CA2666510A1 Process for obtaining legume protein fractions of moderate molecular weight, legume protein fractions and use thereof |
| 05/02/2008 | CA2665024A1 Aqueous pharmaceutical suspensions containing rebamipide and manufacturing process thereof |
| 05/02/2008 | CA2648243A1 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof |
| 05/01/2008 | US20080104718 Transgenic Non-Human Animal Models of Ischemia-Reperfusion Injury and Uses Thereof |
| 05/01/2008 | US20080103294 Amino acid substitutions which increases protease resistance; linked to water soluble polymer (polyethylene glycol); improved half-life |
| 05/01/2008 | US20080103293 Amino acid substitutions which increases protease resistance; linked to water soluble polymer (polyethylene glycol); improved half-life |
| 05/01/2008 | US20080103214 A bioadhesive lubricant that is physiologically tolerated; polyacrylic acid, a water soluble thickener chosen from a cellulose derivative or hyaluronic acid, a humectant and water; viricides or bactericides can be included to prevent infection from mother to child |
| 05/01/2008 | US20080103203 Skin disinfectant |
| 05/01/2008 | US20080103120 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickenier; extended time high blood serum concentration; rapidly absorbed gel |
| 05/01/2008 | US20080103115 Phosphonate compounds |
| 05/01/2008 | US20080103108 Targeted artificial gene delivery |
| 05/01/2008 | US20080103094 Targeted delivery of drugs for the treatment of viral infections |
| 05/01/2008 | US20080103092 Methods for Intradermal, Transdermal or Transmucosal Delivery of Biologically Active Substances |
| 05/01/2008 | US20080102524 Freeze-Dried Composition of Inactivated Virus Envelope with Membrane Fusion Activity |
| 05/01/2008 | US20080102508 Formulation of adenovirus for gene therapy |
| 05/01/2008 | US20080102134 comprising Fluvastatin Sodium, hydroxypropyl methylcellulose polymer and hydroxypropyl cellulose, wherein the granules are independent of particle size; capable of being stored at normal atmospheric conditions |
| 05/01/2008 | US20080102117 Base material for dry direct tableting comprising low-substituted hydroxypropyl cellulose |
| 05/01/2008 | US20080102085 Vaccines for treatment of Aids; protein or polynucleotide is delivered via a bombardment approach |
| 05/01/2008 | US20080102066 Ultrapure transferrin for pharmaceutical compositions |
| 05/01/2008 | US20080102046 Imparting saturated, bright red coloring to skin and lips; interference pigments dispersed in water |
| 05/01/2008 | US20080102037 Stable pharmaceutical budesonide preparation for producing propellant-free aerosols |
| 05/01/2008 | US20080102031 4-[(4-N,N-diethylaminocarbonyl)phenyl]-spiro[2H,1-benzopyran-2,4'-piperidine; ligands of delta opioid receptor; analgesic, anxiolitic, antidepressant, analgesic; gastrointestinal disorders, neurodegenerative diseases; side effect reduction |
| 04/30/2008 | EP1916002A1 Method for prevention of degradation of thermally unstable substance |
| 04/30/2008 | EP1915999A1 N-terminally monopegylated human growth hormone conjugates, process for their preparation, and methods of use thereof. |
| 04/30/2008 | EP1915995A1 Aqueous solution preparation containing camptothecins |
| 04/30/2008 | EP1915990A1 Sustained release preparation |
| 04/30/2008 | EP1915622A2 Screening and therapeutic method for nsclc targeting cdca1-kntc2 complex |
| 04/30/2008 | EP1915413A1 Cationic polymer for transporting nucleic acids in cells |
| 04/30/2008 | EP1915412A2 Method for preparing polymer maleimides |
| 04/30/2008 | EP1915407A2 N-vinylcaprolactam-based copolymers and the use thereof as solubilizers |
| 04/30/2008 | EP1915179A2 Human growth hormone conjugated with biocompatible polymer |
| 04/30/2008 | EP1915178A1 Pharmaceutical formulation with high stability and dissolution and manufacturing process |
| 04/30/2008 | EP1915153A2 Immediate release therapeutic systems for improved oral absorption of 7-[(e)-tert-butyloxyiminomethyl]camtothecin |
| 04/30/2008 | EP1915138A2 Drug-surfactant complexes for sustained release |
| 04/30/2008 | EP1915133A1 Oil-in-water-type emulsion for topical application in dermatology |
| 04/30/2008 | EP1915129A2 Pharmaceutical formulations comprising a long-acting beta2-agonist for administration by nebulisation |
| 04/30/2008 | EP1915128A1 Sterile, drop-forming, multi-phase, emulsifier-free ophthalmic product |
| 04/30/2008 | EP1915117A2 Method for retarding systemic delivery rate for easily absorbable active agents |
| 04/30/2008 | EP1748764B1 An amine drug-containing slow-release granule preparation based on particles with a coating layer and the corresponding method of production |
| 04/30/2008 | EP1631275B1 Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen |